New and innovative interventions in the management of pemphigus

A. S. Frydman, J. A. Fairley

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.

Original languageEnglish (US)
Pages (from-to)211-224
Number of pages14
JournalGiornale Italiano di Dermatologia e Venereologia
Issue number3
StatePublished - Jun 2011

All Science Journal Classification (ASJC) codes

  • Dermatology


Dive into the research topics of 'New and innovative interventions in the management of pemphigus'. Together they form a unique fingerprint.

Cite this